Literature DB >> 1451068

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation.

C L Hanchette1, G G Schwartz.   

Abstract

BACKGROUND: Prostate cancer is the most prevalent nonskin cancer among men in the United States and is the second leading cause of cancer deaths in men. The cause of prostate cancer remains obscure. Recently it was hypothesized that low levels of vitamin D, a hormone with potent antitumor properties, may increase the risk for clinical prostate cancer.
METHODS: Because the major source of vitamin D is casual exposure to ultraviolet (UV) radiation, the authors examined the geographic distributions of UV radiation and prostate cancer mortality in 3073 counties of the contiguous United States using linear regression and trend surface analyses.
RESULTS: The geographic distributions of UV radiation and prostate cancer mortality are correlated inversely (P < 0.0001). Prostate cancer mortality exhibits a significant north-south trend, with lower rates in the South. These geographic patterns are not readily explicable by other known risk factors for prostate cancer.
CONCLUSIONS: These data lend support to the hypothesis that UV radiation may protect against clinical prostate cancer. Viewed in conjunction with other recent data, including those demonstrating a differentiating effect of vitamin D on human prostate cancer cells, these findings suggest that vitamin D may have an important role in the natural history of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451068     DOI: 10.1002/1097-0142(19921215)70:12<2861::aid-cncr2820701224>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  93 in total

1.  The vitamin D receptor: a tumor suppressor in skin.

Authors:  Daniel David Bikle
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  Sunlight and vitamin D: both good for cardiovascular health.

Authors:  Michael F Holick
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

Review 3.  Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes.

Authors:  Asma Arabi; Rola El Rassi; Ghada El-Hajj Fuleihan
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

4.  Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.

Authors:  Pavlo L Kovalenko; Zhentao Zhang; Jun-Ge Yu; Yan Li; Steven K Clinton; James C Fleet
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

5.  Epidemiology of prostate cancer and treatment remarks.

Authors:  Stefano Arcangeli; Valentina Pinzi; Giorgio Arcangeli
Journal:  World J Radiol       Date:  2012-06-28

6.  Chemoprevention of prostate cancer by cholecalciferol (vitamin D3): 25-hydroxylase (CYP27A1) in human prostate epithelial cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells.

Authors:  Erik J Tokar; Mukta M Webber
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

8.  The potential for prostate cancer chemoprevention.

Authors:  Otis W Brawley
Journal:  Rev Urol       Date:  2002

9.  Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States)

Authors:  M M Braun; K J Helzlsouer; B W Hollis; G W Comstock
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

Review 10.  Nonclassic actions of vitamin D.

Authors:  Daniel Bikle
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.